Clinical Trial Update: Restless Legs Syndrome Treatment With Botulinum Toxin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating botulinum toxin for restless legs syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED